Literature DB >> 2176641

Interleukin-3 protects mice from acute herpes simplex virus infection.

W L Chan1, H J Ziltener, F Y Liew.   

Abstract

Evidence presented here from kinetic studies of interleukin-3 (IL-3) production by spleen cells from adult mice infected subcutaneously with HSV-1 and stimulated with virus antigen in vitro shows that high levels of IL-3 were produced at the onset of the animal's recovery from the disease state. Injections of anti-IL-3 antibody into HSV-1-infected mice resulted in exacerbation of the disease. Primary mouse embryonic head cells grown in the presence of murine IL-3, when infected with HSV-1, showed a 1000-fold decrease in virus titre compared with untreated control cells. This inhibiting effect was reversed by anti-IL-3 and anti-IFN-alpha, beta and gamma antibodies. These data suggest that IL-3 plays a host-protective role against HSV infection and it does so probably by inducing brain cells to produce interferons which then inhibit virus replication.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2176641      PMCID: PMC1384432     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  29 in total

1.  Cell-mediated immunity in herpes simplex virus-infected mice: induction, characterization and antiviral effects of delayed type hypersensitivity.

Authors:  A A Nash; H J Field; R Quartey-Papafio
Journal:  J Gen Virol       Date:  1980-06       Impact factor: 3.891

2.  Selective effects of anti-macrophage serum, silica and anti-lymphocyte serum on pathogenesis of herpes virus infection of young adult mice.

Authors:  B Zisman; M S Hirsch; A C Allison
Journal:  J Immunol       Date:  1970-05       Impact factor: 5.422

3.  Role of Lyt-1 positive immune T cells in recovery from herpes simplex virus infection in mice.

Authors:  S Nagafuchi; I Hayashida; K Higa; T Wada; R Mori
Journal:  Microbiol Immunol       Date:  1982       Impact factor: 1.955

4.  P cell-stimulating factor: biochemical characterization of a new T cell-derived factor.

Authors:  I Clark-Lewis; J W Schrader
Journal:  J Immunol       Date:  1981-11       Impact factor: 5.422

5.  Interferon induction in marrow-derived macrophages: regulation by L cell conditioned medium.

Authors:  H B Fleit; M Rabinovitch
Journal:  J Cell Physiol       Date:  1981-09       Impact factor: 6.384

6.  Restriction of herpes simplex virus by macrophages. An analysis of the cell-virus interaction.

Authors:  J G Stevens; M L Cook
Journal:  J Exp Med       Date:  1971-01-01       Impact factor: 14.307

7.  Experimental infection of inbred mice with herpes simplex virus. II. Interferon production and activation of natural killer cells in the peritoneal exudate.

Authors:  H Engler; R Zawatzky; A Goldbach; C H Schröder; C Weyand; G J Hämmerling; H Kirchner
Journal:  J Gen Virol       Date:  1981-07       Impact factor: 3.891

8.  Granulocyte/macrophage-, megakaryocyte-, eosinophil- and erythroid-colony-stimulating factors produced by mouse spleen cells.

Authors:  A W Burgess; D Metcalf; S H Russell; N A Nicola
Journal:  Biochem J       Date:  1980-02-01       Impact factor: 3.857

9.  Long-term in vitro culture of murine mast cells. II. Purification of a mast cell growth factor and its dissociation from TCGF.

Authors:  Y P Yung; R Eger; G Tertian; M A Moore
Journal:  J Immunol       Date:  1981-08       Impact factor: 5.422

10.  THE PATHOGENESIS OF HERPES VIRUS ENCEPHALITIS. II. A CELLULAR BASIS FOR THE DEVELOPMENT OF RESISTANCE WITH AGE.

Authors:  R T JOHNSON
Journal:  J Exp Med       Date:  1964-09-01       Impact factor: 14.307

View more
  6 in total

1.  Recombinant herpes simplex virus type 1 (HSV-1) codelivering interleukin-12p35 as a molecular adjuvant enhances the protective immune response against ocular HSV-1 challenge.

Authors:  Yanira Osorio; Homayon Ghiasi
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

2.  A comparison of T cell responses to glycoprotein B (gB-1) of herpes simplex virus type 1 and its non-glycosylated precursor protein, pgB-1.

Authors:  C A O'Donnell; W L Chan
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

3.  The antiviral activity of tumour necrosis factor on herpes simplex virus type 1: role for a butylated hydroxyanisole sensitive factor.

Authors:  B A Lidbury; I A Ramshaw; M S Rolph; W B Cowden
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

4.  Intestinal protection against Strongyloides ratti and mastocytosis induced by administration of interleukin-3 in mice.

Authors:  T Abe; H Sugaya; K Ishida; W I Khan; I Tasdemir; K Yoshimura
Journal:  Immunology       Date:  1993-09       Impact factor: 7.397

5.  Pre-clinical Assessment of C134, a Chimeric Oncolytic Herpes Simplex Virus, in Mice and Non-human Primates.

Authors:  Kevin A Cassady; David F Bauer; Justin Roth; Melissa R Chambers; Trent Shoeb; Jennifer Coleman; Mark Prichard; G Yancey Gillespie; James M Markert
Journal:  Mol Ther Oncolytics       Date:  2017-03-01       Impact factor: 7.200

6.  Generation of IL-3-Secreting CD4+ T Cells by Microbial Challenge at Skin and Mucosal Barriers.

Authors:  Shajo Kunnath-Velayudhan; Michael F Goldberg; Neeraj K Saini; Tony W Ng; Pooja Arora; Christopher T Johndrow; Noemi Alejandra Saavedra-Avila; Alison J Johnson; Jiayong Xu; John Kim; Nazanin Khajoueinejad; Christopher D Petro; Betsy C Herold; Gregoire Lauvau; John Chan; William R Jacobs; Steven A Porcelli
Journal:  Immunohorizons       Date:  2019-05-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.